Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in <i>LKB1</i> -Mutant Lung Cancer
Junghui Koo(Winship Cancer Institute), Melissa Gilbert‐Ross(Emory Healthcare)
Cited by 4
Related Papers
Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation
|Journal of Biological Chemistry|2015|98
Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma
|JCI Insight|2017|69
GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth
|Oncotarget|2015|21
The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivo
|Communications Biology|2021|6
Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1